لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Oh CR; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.; Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea., Kim EJ; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea., Chae H; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea., Park YS; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Ryu MH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea., Kim HD; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea., Kang YK; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea. ykkang@amc.seoul.kr.

المصدر: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association [Gastric Cancer] 2024 Jul; Vol. 27 (4), pp. 811-818. Date of Electronic Publication: 2024 Mar 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 100886238 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1436-3305 (Electronic) Linking ISSN: 14363291 NLM ISO Abbreviation: Gastric Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Stomach Neoplasms*/drug therapy , Stomach Neoplasms*/pathology , Stomach Neoplasms*/mortality , DNA Mismatch Repair* , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Neoplasm Recurrence, Local*/drug therapy , Neoplasm Recurrence, Local*/pathology, Humans ; Male ; Middle Aged ; Female ; Aged ; Prognosis ; Adult ; Retrospective Studies ; Fluorouracil/administration & dosage ; Fluorouracil/therapeutic use ; Aged, 80 and over ; Survival Rate

المؤلفون: Oh CR; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, 05505, Seoul, Republic of Korea.; Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea., Jeong H; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, 05505, Seoul, Republic of Korea., Kim W; Department of Orthopedic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Lee JS; Department of Orthopedic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Song SY; Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Song JS; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Cho KJ; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Chung HW; Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Lee MH; Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Hong JY; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Lee J; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Kim JE; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, 05505, Seoul, Republic of Korea. jeongeunkim@amc.seoul.kr., Ahn JH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, 05505, Seoul, Republic of Korea. drjiny@amc.seoul.kr.

المصدر: International journal of clinical oncology [Int J Clin Oncol] 2024 Jun; Vol. 29 (6), pp. 853-861. Date of Electronic Publication: 2024 Mar 25.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Fibromatosis, Aggressive*/drug therapy , Fibromatosis, Aggressive*/pathology , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Female ; Male ; Adult ; Retrospective Studies ; Middle Aged ; Young Adult ; Adolescent ; Doxorubicin/therapeutic use ; Doxorubicin/administration & dosage ; Neoplasm Recurrence, Local/drug therapy ; Republic of Korea ; Aged ; Disease Progression

المؤلفون: Oh CR; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea., Kim HD; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Ryu YM; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea., Lee S; Digestive Disease Research Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Kim D; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Lee DS; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Jeong JH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Chang HM; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Ryoo BY; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Kim KP; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Kim M; Department of Medical Science, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Kim SY; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea; sykim3yk@amc.seoul.kr., Yoo C; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; yooc@amc.seoul.kr.

المصدر: Anticancer research [Anticancer Res] 2023 Feb; Vol. 43 (2), pp. 645-652.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Bile Duct Neoplasms*/drug therapy , Biliary Tract Neoplasms*/pathology, Humans ; Epithelial-Mesenchymal Transition/genetics ; Vimentin/genetics ; Cadherins/genetics ; Deoxycytidine/therapeutic use ; Phenotype ; Biomarkers, Tumor

المؤلفون: Oh CR; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea., Kim JE; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Lee JS; Clinical Research Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Kim SY; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Kim TW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Choi J; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Kim J; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Park IJ; Department of Colon and Rectal Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Lim SB; Department of Colon and Rectal Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Park JH; Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Kim JH; Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Choi MK; Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea., Cha Y; Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea., Baek JY; Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea., Beom SH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Hong YS; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: yshong@amc.seoul.kr.

المصدر: Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2023 Feb; Vol. 35 (2), pp. e143-e152. Date of Electronic Publication: 2022 Nov 12.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: W.B. Saunders Country of Publication: England NLM ID: 9002902 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-2981 (Electronic) Linking ISSN: 09366555 NLM ISO Abbreviation: Clin Oncol (R Coll Radiol) Subsets: MEDLINE

مواضيع طبية MeSH: Glioblastoma*/drug therapy , Glioblastoma*/genetics , Glioblastoma*/pathology , Rectal Neoplasms*/drug therapy , Rectal Neoplasms*/genetics , Brain Neoplasms*/therapy, Humans ; Temozolomide/therapeutic use ; Capecitabine ; Dacarbazine/adverse effects ; Prospective Studies ; Chemoradiotherapy ; DNA Repair Enzymes/genetics ; DNA/therapeutic use ; DNA Methylation ; Antineoplastic Agents, Alkylating/therapeutic use

المؤلفون: Oh CR; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea., Kim JE; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Hong YS; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Kim SY; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Ahn JB; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Baek JY; Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea., Lee MA; Department of Oncology, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea., Kang MJ; Division of Oncology, Department of Internal Medicine, Inje University College of Medicine, Haeundae Paik Hospital, Busan, Republic of Korea., Cho SH; Department of Hematology-Oncology, Chonnam National University Hospital, Hwasun, Republic of Korea., Beom SH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Kim TW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

المصدر: International journal of cancer [Int J Cancer] 2022 Jun 15; Vol. 150 (12), pp. 2038-2045. Date of Electronic Publication: 2022 Mar 01.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/pathology , Microsatellite Instability*, Antibodies, Monoclonal ; DNA Mismatch Repair ; Humans ; Prospective Studies

المؤلفون: Yoo C; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Oh CR; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Kim ST; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Bae WK; Division of Hematology-Oncology, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea., Choi HJ; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea., Oh DY; Division of Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea., Lee MA; Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital, Catholic Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea., Ryoo BY; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

المصدر: Cancer research and treatment [Cancer Res Treat] 2021 Apr; Vol. 53 (2), pp. 291-300. Date of Electronic Publication: 2020 Dec 29.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: The Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-9256 (Electronic) Linking ISSN: 15982998 NLM ISO Abbreviation: Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Intestinal Neoplasms/*therapy , Neuroendocrine Tumors/*therapy , Pancreatic Neoplasms/*therapy , Stomach Neoplasms/*therapy, Humans ; Intestinal Neoplasms/mortality ; Neuroendocrine Tumors/mortality ; Pancreatic Neoplasms/mortality ; Progression-Free Survival ; Republic of Korea ; Stomach Neoplasms/mortality

SCR Disease Name: Gastro-enteropancreatic neuroendocrine tumor